D
Eledon Pharmaceuticals, Inc. ELDN
$1.59 $0.117.43% NASDAQ
Recommendation
Prev Close
$1.48
Volume
927,571
Avg Vol (90D)
1,814,492
Market Cap
$111.22M
Dividend & Yield
--
52-Week Range
$1.35 - $5.08
P/E (TTM)
--
EPS (TTM)
-$1.05
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
12/1/2025 - GuruFocus
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
12/1/2025 - Globe Newswire
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Recommendation of "Hold" from Brokerages
11/23/2025 - MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Given Average Recommendation of "Hold" by Brokerages
11/22/2025 - Ticker Report
Guggenheim Cuts Eledon Pharmaceuticals (NASDAQ:ELDN) Price Target to $8.00
11/19/2025 - MarketBeat
Eledon Pharmaceuticals (ELDN) Reports Promising Trial Results for Tegoprubart
11/18/2025 - GuruFocus
Eledon Pharmaceuticals reports preliminary tegoprubart trial results
11/18/2025 - TipRanks Financial Blog
Eledon Pharmaceuticals reports preliminary tegoprubart trial results
11/18/2025 - The Fly
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
11/18/2025 - Globe Newswire
Eledon Pharmaceuticals price target lowered by $1 at Guggenheim, here's why
11/18/2025 - The Fly
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript
11/17/2025 - SeekingAlpha
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript
11/17/2025 - Seeking Alpha: Transcripts
Eledon Pharmaceuticals (NASDAQ:ELDN) Releases Earnings Results, Beats Expectations By $0.01 EPS
11/16/2025 - MarketBeat
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
11/14/2025 - TipRanks Financial Blog
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
11/14/2025 - The Fly
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
11/14/2025 - GuruFocus
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
11/14/2025 - Globe Newswire
Eledon Pharmaceuticals options imply 14.1% move in share price post-earnings
11/14/2025 - TipRanks Financial Blog
Eledon Pharmaceuticals options imply 14.1% move in share price post-earnings
11/14/2025 - The Fly
Eledon Pharmaceuticals (ELDN) Reveals Details of $50M Public Offering
11/12/2025 - GuruFocus
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common ...
11/12/2025 - GuruFocus
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
11/12/2025 - Globe Newswire
Eledon Pharmaceuticals drops 10% on stock offering
11/12/2025 - Seeking Alpha - Healthcare
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and ...
11/11/2025 - GuruFocus
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and ...
11/11/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$86.46M
Net Income (TTM)
-$79.79M
Balance Sheet
Total Assets (Q)
$129.86M
Total Debt (Q)
$722.00K
Total Liabilities (Q)
$38.80M
Book Value Per Share (Q)
$1.52
Cash Flow
Cash from Operations (TTM)
-$67.24M
Cash from Investing (TTM)
-$16.13M
Cash from Financing (TTM)
$80.28M
Net Change in Cash (TTM)
-$3.08M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
1.19
7-Day Total Return
10.42%
30-Day Total Return
-54.44%
60-Day Total Return
-40.67%
90-Day Total Return
-50.77%
Year to Date Total Return
-62.94%
1-Year Total Return
-66.60%
2-Year Total Return
19.55%
3-Year Total Return
-34.57%
5-Year Total Return
-92.98%
52-week Low
Nov 21, 2025 - $1.35
52-week High
Dec 10, 2024 - $5.08
Valuation
Market Cap
$111.22M - Micro Cap
Enterprise Value
$18.54M
Price/Sales (TTM)
--
Price/Book (Q)
0.98
Dividends and Shares
Shares Outstanding
77.27
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
eledon.com
Phone Number
949 238 8090
Address
19800 MacArthur Boulevard
Irvine, CA 92612
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed